Improved host range selection for recombinant modified vaccinia virus Ankara

被引：35

作者：

Staib, C

Löwel, M

Erfle, V

Sutter, G

机构：

[1] GSF, Inst Mol Virol, Natl Res Ctr Environm & Hlth, D-81675 Munich, Germany

[2] Tech Univ Munich, D-8000 Munich, Germany

来源：

BIOTECHNIQUES | 2003年 / 34卷 / 04期

关键词：

D O I：

10.2144/03344bm02

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：694 / +

页数：4

共 14 条

[1] Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine [J].

Amara, RR ;

Villinger, F ;

Altman, JD ;

Lydy, SL ;

O'Neil, SP ;

Staprans, SI ;

Montefiori, DC ;

Xu, Y ;

Herndon, JG ;

Wyatt, LS ;

Candido, MA ;

Kozyr, NL ;

Earl, PL ;

Smith, JM ;

Ma, HL ;

Grimm, BD ;

Hulsey, ML ;

Miller, J ;

McClure, HM ;

McNicholl, JM ;

Moss, B ;

Robinson, HL .

SCIENCE, 2001, 292 (5514) :69-74

[2] Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein [J].

Belyakov, IM ;

Wyatt, LS ;

Ahlers, JD ;

Earl, P ;

Pendleton, CD ;

Kelsall, BL ;

Strober, W ;

Moss, B ;

Berzofsky, JA .

JOURNAL OF VIROLOGY, 1998, 72 (10) :8264-8272

[3]

Drexler I, 1999, CANCER RES, V59, P4955

[4]

Gutierrez CMC, 2002, HUM GENE THER, V13, P1127

[5] Development of a DNA-MVA/HIVA vaccine for Kenya [J].

Hanke, T ;

McMichael, AJ ;

Mwau, M ;

Wee, EGT ;

Ceberej, I ;

Patel, S ;

Sutton, J ;

Tomlinson, M ;

Samuel, RV .

VACCINE, 2002, 20 (15) :1995-1998

[6]

Hill A V, 2000, Dev Biol (Basel), V104, P171

[7] Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: Effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara [J].

Hirsch, VM ;

Fuerst, TR ;

Sutter, G ;

Carroll, MW ;

Yang, LC ;

Goldstein, S ;

Piatak, M ;

Elkins, WR ;

Alvord, WG ;

Montefiori, DC ;

Moss, B ;

Lifson, JD .

JOURNAL OF VIROLOGY, 1996, 70 (06) :3741-3752

[8] Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety [J].

Moss, B .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (21) :11341-11348

[9] Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara [J].

Schneider, J ;

Gilbert, SC ;

Blanchard, TJ ;

Hanke, T ;

Robson, KJ ;

Hannan, CM ;

Becker, M ;

Sinden, R ;

Smith, GL ;

Hill, AVS .

NATURE MEDICINE, 1998, 4 (04) :397-402

[10] Transient host range selection for genetic engineering of modified vaccinia virus Ankara [J].

Staib, C ;

Drexler, I ;

Ohlmann, M ;

Wintersperger, S ;

Erfle, V ;

Sutter, G .

BIOTECHNIQUES, 2000, 28 (06) :1137-+

← 1 2 →